ERS Congress 2017

ERS Congress 2017

European Respiratory Society (ERS) International Congress 2017
MILAN Italy, 9-13 September

ABSTRACTS

Comparing asthma and COPD inhaler devices in real life clinical practice in the UK: differences in training requirements and preference.
Chrystyn H, Benhaddi H, van der Tol M, Voorham J, Haughney J, et al.
Eur Respir J 2017; 50(suppl 61): PA3889. [Full Text]

Real-life evaluation of budesonide/formoterol (DuoResp Spiromax) for the management of asthma and COPD in the UK.
Roche N,Benhaddi H,van der Tol M, Chambers J, van Boven JF, et al.
Eur Respir J 2017; 50(suppl 61): PA937. [Full Text]

Predictive value of FeNO in patients with non-specific respiratory symptoms: a randomised controlled trial.
Price D, Buhl R, Copland A, Freeman D, Godley C, et al.
Eur Respir J 2017; 50(suppl 61): PA3886. [Full Text]

Association between blood eosinophil count and risk of exacerbations in patients with COPD.
Kerkhof M, Rastogi S, Alacqua M, Gopalan G, Halim S, et al.
Eur Respir J 2017; 50(suppl 61): PA3979. [Full Text]

Association between blood eosinophil count and exacerbation risk in patients with asthma receiving medium- or high-dosage inhaled corticosteroids.
Kerkhof M, Tran TN,  van den Berge M, Brusselle G, Gopalan G, et al.
Eur Respir J 2017; 50(suppl 61): PA3994. [Full Text]

Association between blood eosinophil counts and risk of rehospitalization in patients with asthma.
Kerkhof M, Tran TN, van den Berge M, Brusselle G, Gopalan G, et al.
Eur Respir J 2017; 50(suppl 61): OA3214.  [Full Text]